Free Trial

iSpecimen Q4 2023 Earnings Report

iSpecimen logo
$1.34 +0.07 (+5.51%)
As of 04:00 PM Eastern

iSpecimen EPS Results

Actual EPS
-$0.34
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

iSpecimen Revenue Results

Actual Revenue
$2.58 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

iSpecimen Announcement Details

Quarter
Q4 2023
Time
N/A

Conference Call Resources

Remove Ads

iSpecimen Earnings Headlines

🚨This Week: The Political Fallout from Nvidia’s AI Conference
Something big is happening TWO days from now on March 20th — and the political world isn’t ready for it. Nvidia is poised to unveil a groundbreaking AI breakthrough, and the implications could shake Washington, Wall Street, and Main Street alike. While the media focuses on tariff chaos and global conflicts, no one is paying attention to the AI revolution that could shift economic power overnight THIS THURSDAY.
iSpecimen Shares Rise After Securring Virus Suppliers
See More iSpecimen Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like iSpecimen? Sign up for Earnings360's daily newsletter to receive timely earnings updates on iSpecimen and other key companies, straight to your email.

About iSpecimen

iSpecimen (NASDAQ:ISPC) provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Lexington, Massachusetts.

View iSpecimen Profile

More Earnings Resources from MarketBeat